You are here

Article Text

Article menu
Download PDFPDF
Research letter
Challenges of providing HIV pre-exposure prophylaxis in Martinique, French West Indies
  1. Lise Cuzin1,2,
  2. Ornella Cabras1,
  3. Athena Marquise1,
  4. Sandrine Pierre-François1,
  5. Mathilde Pircher1,
  6. André Cabié1
  7. CHUM HIV prevention study group
    1. 1 Infectious and Tropical Diseases, CHU de Martinique, Fort-de-France, Martinique
    2. 2 UPS, Toulouse, France
    1. Correspondence to Dr Lise Cuzin, Infectious and Tropical Diseases, CHU de Martinique, Fort-de-France, 97200, Martinique; lise.cuzin{at}chu-martinique.fr

    http://dx.doi.org/10.1136/sextrans-2021-055158

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Martinique Island is one of the French regions with the highest incidence of HIV infection. Between 1 January 2016 and 31 December 2020, 122 people attended our clinic for their first pre-exposure prophylaxis (PrEP) visit. Two had an HIV diagnosis, 5 decided not to take PrEP and 115 started PrEP. Among those who started PrEP, 104 were men; median age 32 years; 86 self-reported as men having sex with men and 18 as bisexual. By the end of December 2020, 54 of 115 …

      View Full Text

      Footnotes

      • Handling editor Anna Maria Geretti

      • Twitter @maman_poissons

      • Collaborators CHUM HIV prevention study group: Sylvie Abel; Karine Guitteaud; Jean Marie Turmel; Bastien Bigeard; Mélanie Lehoux; Jérémie Pasquier; Rafaelle Theodose; Nicole Desbois; Fatiah Najioullah; Laurence Fagour; Karen Rome.

      • Contributors LC designed the study and recalled the patients, all authors took care of the patients. All authors gave comments on the final report.

      • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

      • Competing interests None declared.

      • Provenance and peer review Not commissioned; internally peer reviewed.